Brain Diseases, Metabolic
"Brain Diseases, Metabolic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Acquired or inborn metabolic diseases that produce brain dysfunction or damage. These include primary (i.e., disorders intrinsic to the brain) and secondary (i.e., extracranial) metabolic conditions that adversely affect cerebral function.
Descriptor ID |
D001928
|
MeSH Number(s) |
C10.228.140.163 C18.452.132
|
Concept/Terms |
Brain Diseases, Metabolic- Brain Diseases, Metabolic
- Brain Disease, Metabolic
- Metabolic Brain Disease
- Metabolic Disorders, Brain
- Brain Metabolic Disorder
- Brain Metabolic Disorders
- Metabolic Disorder, Brain
- Metabolic Encephalopathies
- Metabolic Brain Syndromes
- Brain Syndrome, Metabolic
- Encephalopathies, Metabolic
- Encephalopathy, Metabolic
- Metabolic Encephalopathy
- Metabolic Brain Syndrome
- Metabolic Brain Diseases
- Brain Disorders, Metabolic
- Brain Disorder, Metabolic
- Metabolic Brain Disorder
- Metabolic Brain Disorders
Brain Diseases, Metabolic, Acquired- Brain Diseases, Metabolic, Acquired
- Acquired Metabolic Encephalopathies
- Acquired Metabolic Encephalopathy
- Encephalopathies, Acquired Metabolic
- Encephalopathy, Acquired Metabolic
- Metabolic Encephalopathies, Acquired
- Metabolic Encephalopathy, Acquired
- Brain Disorders, Metabolic, Acquired
- Brain Syndrome, Metabolic, Acquired
- Metabolic Brain Syndrome, Acquired
- Metabolic Brain Syndromes, Acquired
- Encephalopathy, Metabolic, Acquired
- Acquired Metabolic Diseases, Brain
- Metabolic Brain Diseases, Acquired
Central Nervous System Metabolic Disorders- Central Nervous System Metabolic Disorders
- Metabolic Disorders, Central Nervous System
- CNS Metabolic Disorders
- CNS Metabolic Disorder
- Metabolic Disorder, CNS
- Metabolic Disorders, CNS
|
Below are MeSH descriptors whose meaning is more general than "Brain Diseases, Metabolic".
Below are MeSH descriptors whose meaning is more specific than "Brain Diseases, Metabolic".
This graph shows the total number of publications written about "Brain Diseases, Metabolic" by people in this website by year, and whether "Brain Diseases, Metabolic" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2010 | 1 | 0 | 1 | 2016 | 1 | 0 | 1 | 2020 | 1 | 0 | 1 | 2023 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Brain Diseases, Metabolic" by people in Profiles.
-
Vijan A, Khoshpouri P, Murphy AN, Gala F. Glutaric Aciduria Type 1. Radiographics. 2023 11; 43(11):e230114.
-
Houten S, Coughlin CR. Is it time to start to consider treating the liver in glutaric aciduria type 1? J Inherit Metab Dis. 2023 07; 46(4):539-540.
-
Bernstein L, Coughlin CR, Drumm M, Yannicelli S, Rohr F. Inconsistencies in the Nutrition Management of Glutaric Aciduria Type 1: An International Survey. Nutrients. 2020 Oct 16; 12(10).
-
Cost J, Krantz MJ, Mehler PS. Medical complications of anorexia nervosa. Cleve Clin J Med. 2020 06; 87(6):361-366.
-
Goodman SI, Woontner M. An explanation for metabolite excretion in high- and low-excretor patients with glutaric acidemia type 1. Mol Genet Metab. 2019 08; 127(4):325-326.
-
Vendramin Pasquetti M, Meier L, Loureiro S, Ganzella M, Junges B, Barbieri Caus L, Umpierrez Amaral A, Koeller DM, Goodman S, Woontner M, Gomes de Souza DO, Wajner M, Calcagnotto ME. Impairment of GABAergic system contributes to epileptogenesis in glutaric acidemia type I. Epilepsia. 2017 10; 58(10):1771-1781.
-
Rodrigues MDN, Seminotti B, Zanatta ?, de Mello Gon?alves A, Bellaver B, Amaral AU, Quincozes-Santos A, Goodman SI, Woontner M, Souza DO, Wajner M. Higher Vulnerability of Menadione-Exposed Cortical Astrocytes of Glutaryl-CoA Dehydrogenase Deficient Mice to Oxidative Stress, Mitochondrial Dysfunction, and Cell Death: Implications for the Neurodegeneration in Glutaric Aciduria Type I. Mol Neurobiol. 2017 08; 54(6):4795-4805.
-
Schillaci LA, Greene CL, Strovel E, Rispoli-Joines J, Spector E, Woontner M, Scharer G, Enns GM, Gallagher R, Zinn AB, McCandless SE, Hoppel CL, Goodman SI, Bedoyan JK. The M405V allele of the glutaryl-CoA dehydrogenase gene is an important marker for glutaric aciduria type I (GA-I) low excretors. Mol Genet Metab. 2016 09; 119(1-2):50-6.
-
Rodrigues MD, Seminotti B, Amaral AU, Leipnitz G, Goodman SI, Woontner M, de Souza DO, Wajner M. Experimental evidence that overexpression of NR2B glutamate receptor subunit is associated with brain vacuolation in adult glutaryl-CoA dehydrogenase deficient mice: A potential role for glutamatergic-induced excitotoxicity in GA I neuropathology. J Neurol Sci. 2015 Dec 15; 359(1-2):133-40.
-
Amaral AU, Cecatto C, Seminotti B, Ribeiro CA, Lagranha VL, Pereira CC, de Oliveira FH, de Souza DG, Goodman S, Woontner M, Wajner M. Experimental evidence that bioenergetics disruption is not mainly involved in the brain injury of glutaryl-CoA dehydrogenase deficient mice submitted to lysine overload. Brain Res. 2015 Sep 16; 1620:116-29.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|